Status:
COMPLETED
Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?
Lead Sponsor:
Istanbul Training and Research Hospital
Conditions:
Pancreatitis
Lymphocytic Infiltrate
Eligibility:
All Genders
18-80 years
Brief Summary
Pancreatitis is a common complication especially in patients with gallbladder stones, most patients with biliary pancreatitis may recover spontaneously without sequelae, but in 10-20% of patients, the...
Detailed Description
Pancreatitis is a common complication especially in patients with gallbladder stones, most patients with biliary pancreatitis may recover spontaneously without sequelae, but in 10-20% of patients, the...
Eligibility Criteria
Inclusion
- 18-80 years old
- Diagnosis of acute biliary pancreatitis
- Sign the voluntary consent form
Exclusion
- Being under 18 or older than 80
- Not signing the voluntary consent form
- Pancreatitis resulting from an interventional procedure (ERCP, surgery, etc.)
- Pregnant women
- Being a history of immunodeficiency
- Cancer history
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 29 2021
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT04502940
Start Date
June 1 2020
End Date
April 29 2021
Last Update
May 3 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
İstanbul Training and Research Hospital
Istanbul, Turkey (Türkiye), 34098
2
Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi
Istanbul, Turkey (Türkiye), 34900